Skip to main content

Avance Nerve Graft

NDC 84545-430 · Axogen Corporation

Generic nameProcessed nerve allograft

Dosage formIMPLANT

RouteSOFT TISSUE

Active ingredient(s)HUMAN PERIPHERAL NERVE TISSUE

Strength4 mm/30mm

Marketing categoryBLA

Packages

84545-430-01 — 1 CARTON in 1 BAG (84545-430-01) / 1 POUCH in 1 CARTON / 1 POUCH in 1 POUCH / 1 CONTAINER in 1 POUCH / 1 mm in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

84545-115 — Processed nerve allograft, 84545-130 — Processed nerve allograft, 84545-150 — Processed nerve allograft, 84545-170 — Processed nerve allograft, 84545-215 — Processed nerve allograft, 84545-230 — Processed nerve allograft, 84545-250 — Processed nerve allograft, 84545-270 — Processed nerve allograft, 84545-315 — Processed nerve allograft, 84545-330 — Processed nerve allograft, 84545-350 — Processed nerve allograft, 84545-370 — Processed nerve allograft, 84545-415 — Processed nerve allograft, 84545-450 — Processed nerve allograft, 84545-470 — Processed nerve allograft

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels